Skip to main content
Top
Published in: Obesity Surgery 4/2013

01-04-2013 | Economic Aspects

Gastric Bypass is a Cost-Saving Procedure: Results from a Comprehensive Markov Model

Authors: Gil R. Faria, John R. Preto, José Costa-Maia

Published in: Obesity Surgery | Issue 4/2013

Login to get access

Abstract

Background

Obesity is a growing public health problem in industrialized countries and is directly and indirectly responsible for almost 10 % of all health expenditures. Bariatric surgery is the best available treatment, however, associated with important economical expenditures. So, cost-effectiveness analysis of the available surgical options is paramount.

Methods

We developed a Markov model for three different strategies: best medical management, gastric band, and gastric bypass. The Markov model was constructed to allow for the evaluation of the impact of several obesity-related comorbidities. The results were derived for a representative population of morbidly obese patients, and subgroup analyses were performed for patients without comorbidities, patients with diabetes mellitus, different age, and body mass index (BMI) groups. Cost-effectiveness analysis was performed accounting for lifetime costs and from a societal perspective.

Results

Gastric bypass is a dominant strategy, rendering a significant decrease in lifetime costs and increase in quality-adjusted life years (QALYs). Comparing with the best medical management, in the global population of patients with a BMI of >35 kg/m2, gastric bypass renders 1.9 extra QALYs and saves on average 13,244€ per patient. Younger patients, patients with a BMI between 40 and 50 kg/m2, and patients without obesity-related diseases are the ones with a bigger benefit in terms of cost effectiveness.

Conclusions

Gastric bypass surgery increases quality-adjusted survival and saves resources to health systems. As such, it can be an important process to control the ever-increasing health expenditure.
Literature
1.
go back to reference Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic review. J Am Coll Surg. 2005;200(2):270–8.PubMedCrossRef Salem L, Jensen CC, Flum DR. Are bariatric surgical outcomes worth their cost? A systematic review. J Am Coll Surg. 2005;200(2):270–8.PubMedCrossRef
2.
go back to reference Martin LF, Tan TL, Horn JR, et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery. 1995;118(4):599–606. discussion606–7.PubMedCrossRef Martin LF, Tan TL, Horn JR, et al. Comparison of the costs associated with medical and surgical treatment of obesity. Surgery. 1995;118(4):599–606. discussion606–7.PubMedCrossRef
3.
go back to reference Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.PubMedCrossRef Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.PubMedCrossRef
4.
go back to reference Johnson RJ, Johnson BL, Blackhurst DW, et al. Bariatric surgery is associated with a reduced risk of mortality in morbidly obese patients with a history of major cardiovascular events. Am Surg. 2012;78(6):685–92.PubMed Johnson RJ, Johnson BL, Blackhurst DW, et al. Bariatric surgery is associated with a reduced risk of mortality in morbidly obese patients with a history of major cardiovascular events. Am Surg. 2012;78(6):685–92.PubMed
5.
go back to reference Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7.PubMedCrossRef Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7.PubMedCrossRef
6.
go back to reference Ramanan B, Gupta PK, Gupta H, et al. Development and validation of a bariatric surgery mortality risk calculator. J Am Coll Surg. 2012;214(6):892–900.PubMedCrossRef Ramanan B, Gupta PK, Gupta H, et al. Development and validation of a bariatric surgery mortality risk calculator. J Am Coll Surg. 2012;214(6):892–900.PubMedCrossRef
7.
go back to reference SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis. 2009;5(3):387–405.CrossRef SAGES Guidelines Committee. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Obes Relat Dis. 2009;5(3):387–405.CrossRef
8.
go back to reference Terranova L, Busetto L, Vestri A, et al. Bariatric surgery: cost-effectiveness and budget impact. Obes Surg. 2012;22(4):646–53.PubMedCrossRef Terranova L, Busetto L, Vestri A, et al. Bariatric surgery: cost-effectiveness and budget impact. Obes Surg. 2012;22(4):646–53.PubMedCrossRef
9.
go back to reference Mäklin S, Malmivaara A, Linna M, et al. Cost-utility of bariatric surgery for morbid obesity in Finland. Br J Surg. 2011;98(10):1422–9.PubMedCrossRef Mäklin S, Malmivaara A, Linna M, et al. Cost-utility of bariatric surgery for morbid obesity in Finland. Br J Surg. 2011;98(10):1422–9.PubMedCrossRef
10.
go back to reference Chang S-H, Stoll CRT, Colditz GA. Cost-effectiveness of bariatric surgery: should it be universally available? Maturitas. 2011;69(3):230–8.PubMedCrossRef Chang S-H, Stoll CRT, Colditz GA. Cost-effectiveness of bariatric surgery: should it be universally available? Maturitas. 2011;69(3):230–8.PubMedCrossRef
11.
go back to reference Welbourn R, Pournaras D. Bariatric surgery: a cost-effective intervention for morbid obesity; functional and nutritional outcomes. Proc Nutr Soc. 2010;69(4):528–35.PubMedCrossRef Welbourn R, Pournaras D. Bariatric surgery: a cost-effective intervention for morbid obesity; functional and nutritional outcomes. Proc Nutr Soc. 2010;69(4):528–35.PubMedCrossRef
12.
go back to reference Campbell J, McGarry LA, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity. Am J Manag Care. 2010;16(7):e174–87.PubMed Campbell J, McGarry LA, Shikora SA, et al. Cost-effectiveness of laparoscopic gastric banding and bypass for morbid obesity. Am J Manag Care. 2010;16(7):e174–87.PubMed
13.
go back to reference Anselmino M, Bammer T, Fernández Cebrián JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries. Obes Surg. 2009;19(11):1542–9.PubMedCrossRef Anselmino M, Bammer T, Fernández Cebrián JM, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type 2 diabetes in three European countries. Obes Surg. 2009;19(11):1542–9.PubMedCrossRef
14.
go back to reference Salem L, Devlin A, Sullivan SD, et al. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis. 2008;4(1):26–32.PubMedCrossRef Salem L, Devlin A, Sullivan SD, et al. Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis. 2008;4(1):26–32.PubMedCrossRef
15.
go back to reference Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13(4):322–38.PubMedCrossRef Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13(4):322–38.PubMedCrossRef
16.
go back to reference Hunink MGM. Decision making in health and medicine. Cambridge, UK: Cambridge University Press; 2001. Hunink MGM. Decision making in health and medicine. Cambridge, UK: Cambridge University Press; 2001.
17.
go back to reference Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med. 2006;73(11):993–1007.PubMedCrossRef Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med. 2006;73(11):993–1007.PubMedCrossRef
18.
go back to reference Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32(4):567–74.PubMedCrossRef Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009;32(4):567–74.PubMedCrossRef
19.
go back to reference Wadden TA, Sternberg JA, Letizia KA, et al. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int J Obes. 1989;2(13):39–46. Wadden TA, Sternberg JA, Letizia KA, et al. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int J Obes. 1989;2(13):39–46.
20.
go back to reference Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.PubMedCrossRef Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.PubMedCrossRef
21.
go back to reference Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–23. discussion423–4.PubMedCrossRef Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–23. discussion423–4.PubMedCrossRef
22.
go back to reference McEwen LN, Coelho RB, Baumann LM, et al. The cost, quality of life impact, and cost-utility of bariatric surgery in a managed care population. Obes Surg. 2010;20(7):919–28.PubMedCrossRef McEwen LN, Coelho RB, Baumann LM, et al. The cost, quality of life impact, and cost-utility of bariatric surgery in a managed care population. Obes Surg. 2010;20(7):919–28.PubMedCrossRef
23.
go back to reference Arias E. United States life tables, 2006. National vital statistics reports: from the Centers for Disease Control and Prevention (2010). Arias E. United States life tables, 2006. National vital statistics reports: from the Centers for Disease Control and Prevention (2010).
24.
go back to reference Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199(4):543–51.PubMedCrossRef Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199(4):543–51.PubMedCrossRef
25.
go back to reference Brancati FL, Whelton PK, Randall BL, et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA. 1997;278(23):2069–74.PubMedCrossRef Brancati FL, Whelton PK, Randall BL, et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA. 1997;278(23):2069–74.PubMedCrossRef
28.
go back to reference Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.PubMedCrossRef Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.PubMedCrossRef
29.
go back to reference Davis WA, Knuiman MW, Hendrie D, et al. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the fremantle diabetes study. Intern Med J. 2006;36(3):155–61.PubMedCrossRef Davis WA, Knuiman MW, Hendrie D, et al. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the fremantle diabetes study. Intern Med J. 2006;36(3):155–61.PubMedCrossRef
30.
go back to reference American Academy of Sleep Medicine. Cost justification for diagnosis and treatment of obstructive sleep apnea. Position statement of the American Academy of Sleep Medicine. Sleep. 2000;23(8):1017–8. American Academy of Sleep Medicine. Cost justification for diagnosis and treatment of obstructive sleep apnea. Position statement of the American Academy of Sleep Medicine. Sleep. 2000;23(8):1017–8.
31.
go back to reference Gabriel SE, Crowson CS, Campion ME, et al. Direct medical costs unique to people with arthritis. J Rheumatol. 1997;24(4):719–25.PubMed Gabriel SE, Crowson CS, Campion ME, et al. Direct medical costs unique to people with arthritis. J Rheumatol. 1997;24(4):719–25.PubMed
32.
go back to reference Potetz L. Cancer and medicare: a chartbook. Washington, DC: American Cancer Society; 2009. Potetz L. Cancer and medicare: a chartbook. Washington, DC: American Cancer Society; 2009.
33.
go back to reference National Institutes of Health. US Renal Data System (USRDS) annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health. http://www.usrds.org/adr.htm. 2010. National Institutes of Health. US Renal Data System (USRDS) annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health. http://​www.​usrds.​org/​adr.​htm. 2010.
34.
go back to reference Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med. 2002;113(6):491–8.PubMedCrossRef Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med. 2002;113(6):491–8.PubMedCrossRef
35.
go back to reference De Smedt D, De Cocker K, Annemans L, et al. A cost-effectiveness study of the community-based intervention ’10,000 steps Ghent’. Public Health Nutr. 2012;15(3):442–51.PubMedCrossRef De Smedt D, De Cocker K, Annemans L, et al. A cost-effectiveness study of the community-based intervention ’10,000 steps Ghent’. Public Health Nutr. 2012;15(3):442–51.PubMedCrossRef
36.
go back to reference Pollock RF, Valentine WJ, Pilgaard T, et al. The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective. J Med Econ. 2011;14(1):36–46.PubMedCrossRef Pollock RF, Valentine WJ, Pilgaard T, et al. The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective. J Med Econ. 2011;14(1):36–46.PubMedCrossRef
37.
go back to reference Padwal RS, Majumdar SR, Klarenbach S, et al. The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale. BMC Health Serv Res. 2010;10:284.PubMedCrossRef Padwal RS, Majumdar SR, Klarenbach S, et al. The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale. BMC Health Serv Res. 2010;10:284.PubMedCrossRef
38.
go back to reference Ackroyd R, Mouiel J, Chevallier J-M, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006;16(11):1488–503.PubMedCrossRef Ackroyd R, Mouiel J, Chevallier J-M, et al. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg. 2006;16(11):1488–503.PubMedCrossRef
39.
go back to reference Chevallier J-M, Daoud F, Szwarcensztein K, et al. Medicoeconomic evaluation of the treatment of morbid obesity by Swedish adjustable gastric banding (SAGB). Ann Chir. 2006;131(1):12–21.PubMedCrossRef Chevallier J-M, Daoud F, Szwarcensztein K, et al. Medicoeconomic evaluation of the treatment of morbid obesity by Swedish adjustable gastric banding (SAGB). Ann Chir. 2006;131(1):12–21.PubMedCrossRef
40.
go back to reference Reis CEG, Alvarez-Leite JI, Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index. Diabetes Technol Ther. 2012;14(4):365–72.PubMedCrossRef Reis CEG, Alvarez-Leite JI, Bressan J, et al. Role of bariatric-metabolic surgery in the treatment of obese type 2 diabetes with body mass index. Diabetes Technol Ther. 2012;14(4):365–72.PubMedCrossRef
41.
go back to reference Deitel M. Bariatric surgery is a cost-saving for the healthcare system. Obes Surg. 2005;15(3):301–3.PubMedCrossRef Deitel M. Bariatric surgery is a cost-saving for the healthcare system. Obes Surg. 2005;15(3):301–3.PubMedCrossRef
Metadata
Title
Gastric Bypass is a Cost-Saving Procedure: Results from a Comprehensive Markov Model
Authors
Gil R. Faria
John R. Preto
José Costa-Maia
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 4/2013
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-012-0816-8

Other articles of this Issue 4/2013

Obesity Surgery 4/2013 Go to the issue